Eugene Nikitin
Overview
Explore the profile of Eugene Nikitin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pavlova S, Malcikova J, Radova L, Bonfiglio S, Cowland J, Brieghel C, et al.
Hemasphere
. 2025 Jan;
9(1):e70065.
PMID: 39840379
In chronic lymphocytic leukemia, the reliability of next-generation sequencing (NGS) to detect variants ≤10% allelic frequency (low-VAF) is debated. We tested the ability to detect 23 such variants in 41...
2.
Chatzikonstantinou T, Scarfo L, Minga E, Karakatsoulis G, Chamou D, Kotaskova J, et al.
Hemasphere
. 2024 Sep;
8(9):e70004.
PMID: 39290716
No abstract available.
3.
Chatzikonstantinou T, Scarfo L, Karakatsoulis G, Minga E, Chamou D, Iacoboni G, et al.
EClinicalMedicine
. 2023 Nov;
65:102307.
PMID: 38033506
Background: Patients with chronic lymphocytic leukemia (CLL) have a higher risk of developing other malignancies (OMs) compared to the general population. However, the impact of CLL-related risk factors and CLL-directed...
4.
Ptushkin V, Arshanskaya E, Vinogradova O, Kudlay D, Nikitin E
Hematol Rep
. 2023 Sep;
15(3):503-512.
PMID: 37754667
COVID-19 and other infectious diseases can exacerbate the course of paroxysmal nocturnal hemoglobinuria (PNH). The efficacy and safety of the Gam-COVID-Vac vaccine in patients with PNH has not been adequately...
5.
Cochrane T, Enrico A, Gomez-Almaguer D, Hadjiev E, Lech-Maranda E, Masszi T, et al.
Leuk Lymphoma
. 2023 Aug;
65(11):1743-1746.
PMID: 37626019
No abstract available.
6.
Nikitin E, Kislova M, Morozov D, Belyakova V, Suvorova A, Sveshnikova J, et al.
Leukemia
. 2023 May;
37(7):1464-1473.
PMID: 37202442
Autoimmune hemolytic anemia (AIHA) and pure red cell aplasia (PRCA) are common complications of CLL. The optimal treatment of steroid refractory AIHA/PRCA is not well established. We conducted a multicenter...
7.
Niemann C, Awan F, Fogliatto L, Nikitin E, Samoilova O, Habib A, et al.
Hemasphere
. 2022 Sep;
6(10):e780.
PMID: 36168519
No abstract available.
8.
Cochrane T, Enrico A, Gomez-Almaguer D, Hadjiev E, Lech-Maranda E, Masszi T, et al.
Leuk Lymphoma
. 2021 Oct;
63(2):304-314.
PMID: 34632935
Venetoclax, a potent B-cell lymphoma-2 (BCL-2) inhibitor, has demonstrated clinical efficacy in chronic lymphocytic leukemia (CLL). VENICE II is an open-label, single-arm, phase 3b study (NCT02980731) evaluating the impact of...
9.
Scarfo L, Chatzikonstantinou T, Rigolin G, Quaresmini G, Motta M, Vitale C, et al.
Leukemia
. 2020 Jul;
34(9):2354-2363.
PMID: 32647324
Chronic lymphocytic leukemia (CLL) is a disease of the elderly, characterized by immunodeficiency. Hence, patients with CLL might be considered more susceptible to severe complications from COVID-19. We undertook this...
10.
Chigrinova E, Rinaldi A, Kwee I, Rossi D, Rancoita P, Strefford J, et al.
Blood
. 2013 Sep;
122(15):2673-82.
PMID: 24004666
Richter syndrome (RS) occurs in up to 15% of patients with chronic lymphocytic leukemia (CLL). Although RS, usually represented by the histologic transformation to a diffuse large B-cell lymphoma (DLBCL),...